Maria Grigoroiu-Serbanescu1, Marcella Rietschel2, Joanna Hauser3, Piotr M Czerski3, Stefan Herms4, Xianqing Sun5, Priya Wickramaratne6, Robert C Elston5. 1. Biometric Psychiatric Genetics Research Unit, Alexandru Obregia Clinical Psychiatric Hospital, 10, Sos. Berceni, R-041914 Bucharest, Romania. Electronic address: maria.serbanescu@googlemail.com. 2. Central Institute for Mental Health, Division Genetic Epidemiology in Psychiatry, Mannheim, Germany. 3. Laboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, Poznan, Poland. 4. University Hospital Basel, Research Group Genomics, Medical Genetics, Basel, Switzerland. 5. Case Western Reserve University School of Medicine, Department of Epidemiology and Biostatistics, Cleveland, OH, USA. 6. Department of Psychiatry, College of Physicians and Surgeons, and Department of Biostatistics, Joseph L. Mailman School of Public Health, Columbia University; Division of Clinical and Genetic Epidemiology, New York State Psychiatric Institute, New York, New York, USA.
Abstract
BACKGROUND: Age-of-onset (AO) is increasingly used in molecular genetics of bipolar I disorder (BP-I) as a phenotypic specifier with the goal of reducing genetic heterogeneity. However, questions regarding the cut-off age for defining early onset (EO), as well as the number of onset groups characterizing BP-I have emerged over the last decade with no definite conclusion. The aims of this paper are: 1) to see whether a mixture of three distributions better describes the AO of BP-I than a mixture of two distributions in different independent samples; 2) to compare the morbid risk (MR) for BP-I and for major affective disorders and schizophrenia in first degree relatives of BP-I probands by proband onset group derived from commingling analysis, since the MR to relatives is a trait with strong genetic background. METHODS: We applied commingling (admixture) analysis to the AO of three BP-I samples from Romania (n=621), Germany (n=882), and Poland (n=354). Subsequently, the morbid risk (MR) for BP-I and for major psychoses (BP-I, BP-II, Mdd-UP, schizoaffective disorders, schizophrenia) was estimated in first degree relatives by proband AO-group derived from admixture analysis in the Romanian sample. RESULTS: In the three independent samples and in the combined sample two- and three-AO-group distributions fitted the empirical data equally well. The upper EO limit varied between 21 and 25 years from sample to sample. The MR for both BP-I and for all major psychoses was similar in first degree relatives of EO probands (AO≤21) and in relatives of intermediate-onset probands (AO=22-34). Significant MR differences appeared only when comparing the EO group to the late-onset (LO) group (AO>34). Similar to Mdd-UP and schizophrenia, a significant MR decrease in proband first degree relatives was visible after proband AO of 34 years. Under the three-AO-group classification the MR for both BP-I and all major psychoses in first degree relatives did not differ by relative sex in any proband AO-group. Under the two-AO-group classification female relatives of LO probands (AO>24) had a significantly higher MR for all major psychoses than male relatives, while there was no sex difference for the relatives of EO probands. LIMITATIONS: MR was not computed in the German and Polish samples because family data were not available and 34% of the relatives of the Romanian probands were not available for direct interview. CONCLUSION: Similar to other clinical traits, the MR for major psychoses to relatives failed to support a three-AO-group classification in BP-I suggesting that this is not more useful for the molecular analysis than a two-AO-group classification.
BACKGROUND: Age-of-onset (AO) is increasingly used in molecular genetics of bipolar I disorder (BP-I) as a phenotypic specifier with the goal of reducing genetic heterogeneity. However, questions regarding the cut-off age for defining early onset (EO), as well as the number of onset groups characterizing BP-I have emerged over the last decade with no definite conclusion. The aims of this paper are: 1) to see whether a mixture of three distributions better describes the AO of BP-I than a mixture of two distributions in different independent samples; 2) to compare the morbid risk (MR) for BP-I and for major affective disorders and schizophrenia in first degree relatives of BP-I probands by proband onset group derived from commingling analysis, since the MR to relatives is a trait with strong genetic background. METHODS: We applied commingling (admixture) analysis to the AO of three BP-I samples from Romania (n=621), Germany (n=882), and Poland (n=354). Subsequently, the morbid risk (MR) for BP-I and for major psychoses (BP-I, BP-II, Mdd-UP, schizoaffective disorders, schizophrenia) was estimated in first degree relatives by proband AO-group derived from admixture analysis in the Romanian sample. RESULTS: In the three independent samples and in the combined sample two- and three-AO-group distributions fitted the empirical data equally well. The upper EO limit varied between 21 and 25 years from sample to sample. The MR for both BP-I and for all major psychoses was similar in first degree relatives of EO probands (AO≤21) and in relatives of intermediate-onset probands (AO=22-34). Significant MR differences appeared only when comparing the EO group to the late-onset (LO) group (AO>34). Similar to Mdd-UP and schizophrenia, a significant MR decrease in proband first degree relatives was visible after proband AO of 34 years. Under the three-AO-group classification the MR for both BP-I and all major psychoses in first degree relatives did not differ by relative sex in any proband AO-group. Under the two-AO-group classification female relatives of LO probands (AO>24) had a significantly higher MR for all major psychoses than male relatives, while there was no sex difference for the relatives of EO probands. LIMITATIONS: MR was not computed in the German and Polish samples because family data were not available and 34% of the relatives of the Romanian probands were not available for direct interview. CONCLUSION: Similar to other clinical traits, the MR for major psychoses to relatives failed to support a three-AO-group classification in BP-I suggesting that this is not more useful for the molecular analysis than a two-AO-group classification.
Authors: X Xiao; C Zhang; M Grigoroiu-Serbanescu; L Wang; L Li; D Zhou; T-F Yuan; C Wang; H Chang; Y Wu; Y Li; D-D Wu; Y-G Yao; M Li Journal: Mol Psychiatry Date: 2017-11-21 Impact factor: 15.992
Authors: Mirko Manchia; Giuseppe Maina; Bernardo Carpiniello; Federica Pinna; Luca Steardo; Virginia D'Ambrosio; Virginio Salvi; Martin Alda; Alfonso Tortorella; Umberto Albert Journal: Int J Bipolar Disord Date: 2017-08-21
Authors: Janos L Kalman; Sergi Papiol; Andreas J Forstner; Urs Heilbronner; Franziska Degenhardt; Jana Strohmaier; Mazda Adli; Kristina Adorjan; Nirmala Akula; Martin Alda; Heike Anderson-Schmidt; Till Fm Andlauer; Ion-George Anghelescu; Raffaella Ardau; Bárbara Arias; Volker Arolt; Jean-Michel Aubry; Lena Backlund; Kim Bartholdi; Michael Bauer; Bernhard T Baune; Thomas Becker; Frank Bellivier; Antonio Benabarre; Susanne Bengesser; Abesh Kumar Bhattacharjee; Joanna M Biernacka; Armin Birner; Clara Brichant-Petitjean; Monika Budde; Pablo Cervantes; Caterina Chillotti; Sven Cichon; Scott R Clark; Francesc Colom; Ashley L Comes; Cristiana Cruceanu; Piotr M Czerski; Udo Dannlowski; Alexandre Dayer; Maria Del Zompo; Jay Raymond DePaulo; Detlef E Dietrich; Bruno Étain; Thomas Ethofer; Peter Falkai; Andreas Fallgatter; Christian Figge; Laura Flatau; Here Folkerts; Louise Frisen; Mark A Frye; Janice M Fullerton; Katrin Gade; Sébastien Gard; Julie S Garnham; Fernando S Goes; Maria Grigoroiu-Serbanescu; Anna Gryaznova; Maria Hake; Joanna Hauser; Stefan Herms; Per Hoffmann; Liping Hou; Markus Jäger; Stephane Jamain; Esther Jiménez; Georg Juckel; Jean-Pierre Kahn; Layla Kassem; John Kelsoe; Sarah Kittel-Schneider; Sebastian Kliwicki; Farah Klohn-Sagatholislam; Manfred Koller; Barbara König; Carsten Konrad; Nina Lackner; Gonzalo Laje; Mikael Landén; Fabian U Lang; Catharina Lavebratt; Marion Leboyer; Susan G Leckband; Mario Maj; Mirko Manchia; Lina Martinsson; Michael J McCarthy; Susan L McElroy; Francis J McMahon; Philip B Mitchell; Marina Mitjans; Francis M Mondimore; Palmiero Monteleone; Vanessa Nieratschker; Caroline M Nievergelt; Tomas Novák; Urban Ösby; Andrea Pfennig; James B Potash; Daniela Reich-Erkelenz; Andreas Reif; Jens Reimer; Eva Reininghaus; Markus Reitt; Stephan Ripke; Guy A Rouleau; Janusz K Rybakowski; Martin Schalling; Harald Scherk; Max Schmauß; Peter R Schofield; K Oliver Schubert; Eva C Schulte; Sybille Schulz; Fanny Senner; Giovanni Severino; Tatyana Shekhtman; Paul D Shilling; Christian Simhandl; Claire M Slaney; Carsten Spitzer; Alessio Squassina; Thomas Stamm; Sophia Stegmaier; Sebastian Stierl; Pavla Stopkova; Andreas Thiel; Sarah K Tighe; Alfonso Tortorella; Gustavo Turecki; Eduard Vieta; Julia Veeh; Martin von Hagen; Moritz E Wigand; Jens Wiltfang; Stephanie Witt; Adam Wright; Peter P Zandi; Jörg Zimmermann; Markus Nöthen; Marcella Rietschel; Thomas G Schulze Journal: Bipolar Disord Date: 2018-06-28 Impact factor: 6.744